ATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company focused
on aortic disease, announced today that members of management will
host one-on-one meetings at the upcoming Canaccord Genuity MedTech,
Diagnostics, and Digital Health & Services Forum on
Thursday, November 18, 2021. Due to
the format of this event no webcast will be available.
For more information on the company, please visit CryoLife's
website, www.cryolife.com, on the Investor Relations page.
About CryoLife, Inc.
Headquartered in suburban
Atlanta, Georgia, CryoLife is a
leader in the manufacturing, processing, and distribution of
medical devices and implantable tissues used in cardiac and
vascular surgical procedures focused on aortic repair. CryoLife
markets and sells products in more than 100 countries worldwide.
For additional information about CryoLife, visit our website,
www.cryolife.com.
|
Contacts:
|
|
|
|
|
CryoLife
D. Ashley
Lee
Executive Vice
President, Chief Financial Officer
and Chief Operating
Officer
Phone:
770-419-3355
|
Gilmartin Group
LLC
Brian Johnston / Lynn
Lewis
Phone:
631-807-1986
investors@cryolife.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health--services-forum-301420321.html
SOURCE CryoLife, Inc.